logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12502380 B1

PDFFull Text
Date of Patent:
Dec. 23, 2025

Filed:

Oct. 22, 2024

Mrgprx2 antagonists for the treatment of inflammatory disorders

Applicant:

Dermira, Inc., Menlo Park, CA (US);

Inventors:

Ferda Cevikbas, Menlo Park, CA (US);

Ashley Jarvis, Menlo Park, CA (US);

Laura Gleave, Menlo Park, CA (US);

Nina Connelly Ursinyova, Menlo Park, CA (US);

Ricky Cain, Menlo Park, CA (US);

Wei Tsung Yau, Menlo Park, CA (US);

Assignee:

Dermira, Inc., Menlo Park, CA (US);

Attorneys:

Rudy J. Ng

Bozicevic, Field & Francis LLP

Primary Examiner:

James H Alstrum-Acevedo

Assistant Examiner:

Lauren undefined Wells

Int. Cl.
CPC ...
A61K 31/427 (2006.01); A61K 31/4184 (2006.01); A61K 31/42 (2006.01); A61K 31/426 (2006.01); A61K 31/428 (2006.01); A61K 31/4439 (2006.01); A61K 31/454 (2006.01); A61K 31/5377 (2006.01);
U.S. Cl.
CPC ...
A61K 31/427 (2013.01); A61K 31/4184 (2013.01); A61K 31/42 (2013.01); A61K 31/426 (2013.01); A61K 31/428 (2013.01); A61K 31/4439 (2013.01); A61K 31/454 (2013.01); A61K 31/5377 (2013.01);
Abstract

The present disclosure is directed to use of MrgprX2 antagonists in the treatment of inflammatory disorders, e.g., inflammatory disorders of the skin. This invention is also directed to pharmaceutical compositions comprising a MrgprX2 antagonist and a pharmaceutically or orally acceptable carrier for administration.

Find Patent Forward Citations

Quick Actions:

Cevikbas, Ferda. (2025). Mrgprx2 antagonists for the treatment of inflammatory disorders (U.S. Patent No. 12502380). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12502380

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…